← Back to Search

Barrier Method

Synthetic Nitrile vs Latex Condoms for STI Prevention

N/A
Recruiting
Led By Mags Beksinska, PhD
Research Sponsored by Karex Industries Sdn. Bhd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 - 5 months
Awards & highlights

Study Summary

This trial compares how well 3 types of male condoms protect against pregnancy.

Who is the study for?
Couples aged 18-45, in a monogamous relationship for at least 3 months, who are sexually active and agree to use only study condoms and lubricant. Excludes those with allergies to latex or nitrile, STI symptoms or HIV positive status, pregnant women or those wanting pregnancy soon, participants in other condom studies, employees of the trial's institutions, sex workers, men with sexual dysfunction and individuals with genital piercings.Check my eligibility
What is being tested?
The trial is testing two sizes of synthetic nitrile male condoms against a standard latex condom. Participants will use each type over three periods while reporting on their performance during intercourse. The study aims to assess how well these new condoms work compared to the traditional ones.See study design
What are the potential side effects?
Potential side effects may include allergic reactions if sensitivity to materials exists (though people with known allergies are excluded), discomfort during use depending on individual fit and preference for material type.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 - 5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 - 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical breakage
Clinical failure
Clinical slippage
Secondary outcome measures
Acceptability
Genital discomfort
Non-Clinical breakage
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Synthetic Nitrile Condoms (56mm)Experimental Treatment1 Intervention
56mm width synthetic nitrile condoms
Group II: Synthetic Nitrile Condoms (53mm)Experimental Treatment1 Intervention
53mm width synthetic nitrile condoms
Group III: Control Latex CondomActive Control1 Intervention
Commercial natural rubber latex condom

Find a Location

Who is running the clinical trial?

Karex Industries Sdn. Bhd.Lead Sponsor
1 Previous Clinical Trials
600 Total Patients Enrolled
University of Witwatersrand, South AfricaOTHER
98 Previous Clinical Trials
9,943,736 Total Patients Enrolled
Essential Access HealthOTHER
6 Previous Clinical Trials
2,270 Total Patients Enrolled

Media Library

Control Latex Condom (Barrier Method) Clinical Trial Eligibility Overview. Trial Name: NCT05912283 — N/A
Sexually Transmitted Infections Research Study Groups: Synthetic Nitrile Condoms (56mm), Control Latex Condom, Synthetic Nitrile Condoms (53mm)
Sexually Transmitted Infections Clinical Trial 2023: Control Latex Condom Highlights & Side Effects. Trial Name: NCT05912283 — N/A
Control Latex Condom (Barrier Method) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05912283 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the intended purpose of this medical experiment?

"This trial will be assessing the efficacy of clinical breakage over a period ranging from 3 to 5 months. Secondary metrics such as acceptability, non-clinical breakage and non-clinical slippage are also being tracked for statistical analysis. These parameters consist of comfort in use, ease of insertion/removal, like or dislike of product attributes, lubrication adequacy and feel etc., plus quantifying any possible breakages before sexual intercourse or after withdrawal from vagina and partial slipping during sexual intercourse respectively."

Answered by AI

What is the total number of participants that have been enrolled in this research?

"Affirmative. According to clinicaltrials.gov, this medical study - first posted on June 2nd 2023 - is currently recruiting patients with 600 participants required from 3 different sites."

Answered by AI

What qualifications are required to join this medical study?

"Patients that wish to join this clinical trial must have a sexually transmitted infection and be in the age range of 18-45. In total, 600 participants are being accepted."

Answered by AI

Does this research initiative accept participants aged 55 and above?

"This research study is actively seeking volunteers aged 18 to 45."

Answered by AI

Are there any remaining vacancies for participants in this experiment?

"As reported on clinicaltrials.gov, this trial is still recruiting patients. It was first announced on June 2nd 2023 and the information has been updated as recently as June 12th of that same year."

Answered by AI
~327 spots leftby Apr 2025